<DOC>
	<DOCNO>NCT00004402</DOCNO>
	<brief_summary>OBJECTIVES : I . Compare rate treatment failure osteopetrosis patient receive interferon gamma combination calcitriol rate treatment failure patient receive calcitriol alone . II . Compare number adverse event clinical manifestation disease progression occur patient . III . Assess effect interferon gamma hematopoiesis , cranial nerve function , rate infection patient .</brief_summary>
	<brief_title>Phase III Randomized Study Interferon Gamma Children With Severe , Congenital Osteopetrosis</brief_title>
	<detailed_description>PROTOCOL OUTLINE : This randomize , placebo control , open label study . Patients randomize one two arm ( interferon gamma combination calcitriol calcitriol alone ) . Arm I : Patients receive calcitriol daily . Interferon gamma administer subcutaneous injection three time week . Arm II : Patients receive calcitriol daily . Patients may continue treatment absence toxicity disease progression . If disease progression diagnose control group , patient receive interferon gamma combination calcitriol . Patients follow every 4 week .</detailed_description>
	<mesh_term>Osteopetrosis</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon-gamma</mesh_term>
	<mesh_term>Calcitriol</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Biopsy xray confirm primary osteopetrosis Presence anemia and/or cranial nerve compression Prior/Concurrent Therapy Biologic therapy : No prior/concurrent bone marrow transplantation No prior interferon gamma No investigational biologic agent Chemotherapy : No prior/concurrent chemotherapeutic agent bone marrow transplantation Endocrine therapy : Prior/concurrent corticosteroid supportive therapy allow Radiotherapy : Not specify Surgery : At least 5 day since major surgery Other : Prior/concurrent calcitriol supportive therapy allow Prior/concurrent transfusion supportive therapy allow Prior/concurrent dietary therapy allow Patient Characteristics Age : 2 month 10 year Performance status : Not specify Life expectancy : At least 6 month Hematopoietic : Not specify Hepatic : Bilirubin le 2 mg/dL Renal : Creatinine le 1.5 mg/dL OR Creatinine clearance great 50 mL/min Pulmonary : No uncorrected airway obstruction Other : No active infection require intravenous antibiotic No known seizure disorder relate hypocalcemia No uncorrected hydrocephalus No MRI evidence cerebral atrophy Must maintain gain body weight No sleep apnea No thrombocytopenia No massive splenomegaly</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>January 2001</verification_date>
	<keyword>genetic disease dysmorphic syndrome</keyword>
	<keyword>osteopetrosis</keyword>
	<keyword>rare disease</keyword>
</DOC>